Effects of resveratrol on the amelioration of insulin resistance in KKA y mice

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 2, 2012, Pages 237-242

  Chen, Sifan ^a,b   Li, Jinghua ^b   Zhang, Zili ^b   Li, Wenxue ^a,b   Sun, Yanshuang ^b   Zhang, Quanxin ^a   Feng, Xiang ^b   Zhu, Wei ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

AKT; AMPK; Insulin resistance; IRS1; Resveratrol; Sirt1

Indexed keywords

ADIPONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLEUS MUSCLE;

ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIRTUIN 1; STILBENES; TIME FACTORS;

EID: 84863153155     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-123     Document Type: Article

References (22)

1. Ahima, R.S. 2006. Adipose tissue as an endocrine organ. Obesity (Silver Spring), 14(Suppl. 5): 242S-249S. doi:10.1038/oby.2006.317. PMID:17021375.
2. Asano, T., Fujishiro, M., Kushiyama, A., Nakatsu, Y., Yoneda, M., Kamata, H., and Sakoda, H. 2007. Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. Biol. Pharm. Bull. 30(9): 1610-1616. doi:10.1248/bpb.30.1610. PMID:17827708.
3. Castle, C.K., Colca, J.R., and Melchior, G.W. 1993. Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulinsensitizing agent pioglitazone. Arterioscler. Thromb. Vasc. Biol. 13(2): 302-309. doi:10.1161/01.ATV.13.2.302. PMID:8427865.
4. Cucciolla, V., Borriello, A., Oliva, A., Galletti, P., Zappia, V., and Della Ragione, F. 2007. Resveratrol: from basic science to the clinic. Cell Cycle, 6(20): 2495-2510. doi:10.4161/cc.6.20.4815. PMID:17726376.
5. Feige, J.N., Lagouge, M., Canto, C., Strehle, A., Houten, S.M., Milne, J.C., et al. 2009. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 9(2): 210-218. doi:10.1016/j.cmet.2009.01.005. PMID:19046567.
6. Fryer, L.G., Foufelle, F., Barnes, K., Baldwin, S.A., Woods, A., and Carling, D. 2002. Characterization of the role of the AMPactivated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem. J. 363(1): 167-174. doi:10.1042/0264-6021:3630167. PMID:11903059.
7. Imai, S. 2009. SIRT1 and caloric restriction: an insight into possible tradeoffs between robustness and frailty. Curr. Opin. Clin. Nutr. Metab. Care, 12(4): 350-356. doi:10.1097/MCO.0b013e32832c932d. PMID:19474721.
8. Knight, Z.A., Gonzalez, B., Feldman, M.E., Zunder, E.R., Goldenberg, D.D., Williams, O., et al. 2006. A pharmacological map of the PI3-K family defines a role for p110a in insulin signaling. Cell, 125(4): 733-747. doi:10.1016/j.cell.2006.03.035. PMID:16647110.
9. Koistinen, H.A., Galuska, D., Chibalin, A.V., Yang, J., Zierath, J.R., Holman, G.D., and Wallberg-Henriksson, H. 2003. 5-Aminoimidazole carboxamide riboside increases glucose transport and cell surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes, 52(5): 1066-1072. doi:10.2337/diabetes.52.5.1066. PMID:12716734.
10. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 a. Cell, 127(6): 1109-1122. doi:10.1016/j.cell.2006.11.013. PMID:17112576.
11. Lan, F., Cacicedo, J.M., Ruderman, N., and Ido, Y. 2008. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283(41): 27628-27635. doi:10.1074/jbc.M805711200. PMID:18687677.
12. Nam, J.S., Nam, J.Y., Yoo, J.S., Cho, M., Park, J.S., Ahn, C.W., et al. 2010. The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation. Diabetes Res. Clin. Pract. 87 (3): 329-334. doi:10.1016/j.diabres.2009.12.021. PMID:20060191.
13. Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M., and Tschöp, M.H. 2008. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U.S.A. 105(28): 9793-9798. doi:10.1073/pnas.0802917105. PMID:18599449.
14. Pittas, A.G., Joseph, N.A., and Greenberg, A.S. 2004. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89(2): 447-452. doi:10.1210/jc.2003-031005. PMID:14764746.
15. Rayalam, S., Yang, J.Y., Ambati, S., Della-Fera, M.A., and Baile, C. A. 2008. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 22(10): 1367-1371. doi:10.1002/ptr.2503. PMID:18688788.
16. Reaven, G.M. 1988. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes, 37(12): 1595-1607. doi:10.2337/diabetes.37.12.1595. PMID:3056758.
17. Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., and Cantley, L.C. 2004. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101(10): 3329-3335. doi:10.1073/pnas.0308061100. PMID:14985505.
18. Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., and Zhai, Q. 2007. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6(4): 307-319. doi:10.1016/j.cmet.2007.08.014.
19. Turnley, A.M., Stapleton, D., Mann, R.J., Witters, L.A., Kemp, B.E., and Bartlett, P.F. 1999. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 72(4): 1707-1716. doi:10.1046/j.1471-4159.1999.721707.x. PMID:10098881.
20. Wright, D.C., Geiger, P.C., Holloszy, J.O., and Han, D.H. 2005. Contraction and hypoxia-stimulated glucose transport is mediated by a Ca2+ dependent mechanism in slow-twitch rat soleus muscle. Am. J. Physiol. Endocrinol. Metab. 288(6): E1062-E1066. doi:10.1152/ajpendo.00561.2004. PMID:15657088.
21. Yamamoto, H., Schoonjans, K.J.A., and Auwerx, J. 2007. Sirtuin functions in health and disease. Mol. Endocrinol. 21(8): 1745-1755. doi:10.1210/me.2007-0079. PMID:17456799.
22. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8(11): 1288-1295. doi:10.1038/nm788. PMID:12368907.